Projects / Programmes
Prevention of ischaemic events in patients with peripheral arterial disease - Laboratory markers of ischaemic events
Code |
Science |
Field |
Subfield |
3.06.00 |
Medical sciences |
Cardiovascular system |
|
Code |
Science |
Field |
B530 |
Biomedical sciences |
Cardiovascular system |
atherosclerosis, peripheral arterial disease, cardiovascular event, risk factors, haemostasis activation markers, adhesion molecules, inflammation markers, genetic polymorphisms
Researchers (9)
no. |
Code |
Name and surname |
Research area |
Role |
Period |
No. of publicationsNo. of publications |
1. |
07630 |
PhD Aleš Blinc |
Cardiovascular system |
Researcher |
2005 - 2008 |
500 |
2. |
15637 |
PhD Mojca Božič Mijovski |
Cardiovascular system |
Researcher |
2005 - 2008 |
211 |
3. |
08799 |
Matija Cevc |
Cardiovascular system |
Researcher |
2005 - 2008 |
137 |
4. |
11685 |
PhD Zlatko Fras |
Cardiovascular system |
Researcher |
2005 - 2008 |
788 |
5. |
05965 |
PhD Matija Kozak |
Cardiovascular system |
Researcher |
2005 - 2008 |
333 |
6. |
05034 |
PhD Mojca Stegnar |
Cardiovascular system |
Head |
2005 - 2008 |
343 |
7. |
08094 |
PhD Mirza Šabovič |
Cardiovascular system |
Researcher |
2005 - 2008 |
423 |
8. |
18377 |
PhD Monika Štalc |
Cardiovascular system |
Researcher |
2005 - 2008 |
123 |
9. |
03392 |
MSc Viktor Videčnik |
Cardiovascular system |
Researcher |
2005 - 2008 |
103 |
Organisations (1)
Abstract
Peripheral arterial disease (PAD) confirmed by reduced ankle-brachial pressure index is associated with increased mortality due to myocardial infarction and ischemic stroke. Studies describe 2 to 3-fold greater mortality in patients with PAD than in age-matched controls with normal ankle-brachial pressure index, with a 5-year mortality of about 30% in patients with advanced PAD. Risk factors for PAD are the same as for coronary heart disease, where they were shown to explain most of the risk for myocardial infarction.. The predictive value of haemostatic and inflammatory markers in patients with PAD is not well established.
The study is designed as a prospective comparison of patients with documented PAD and age- and sex-matched controls with normal ankle-brachial pressure index. Both groups will receive recommended cardiovascular preventive measures according to the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Primary end-points of the study are major ischemic events: myocardial infarction, ischemic stroke and cardio-vascular death. Secondary end-points are the need for peripheral vascular revascularization, coronary artery revascularization, carotid artery revascularization and the need for repair of abdominal aortic aneurysm. In the study at least 1000 patients with reduced ankle-brachial pressure index (< 0.9) and the same number of age-matched and sex-matched controls with normal ankle-brachial pressure index (0.91 – 1.30) will be investigated. At the initial examination, all subjects will be interviewed on their personal and family history, a physical examination will be performed including anthropometric measurements. Urine will be tested for glucose and albumin. Venous blood will be drawn for routine tests and haemostatic and inflammation markers (fibrinogen, high sensitive CRP, VCAM-1, soluble P-selectin, soluble von Wilebrand factor, D-dimer, polymorphisms in genes for platelet receptors GP IIb/IIIa and Ia/Iia). End-points wiull be recorded in all subjects included.
It is expected that that the study will confirm the hypothesis that cardio-vascular ischemic events are more frequent in patients with PAD receiving secondary prevention measures than in age and sex-matched control subjects with normal ankle-brachial pressure index and that haemostatic and inflammatory markers are predictive factors for cardio-vascular ischemic events in patients with PAD.